CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and ...

I finally felt like a survivor the day I heard my 18-month scans were clear, shifting from fear to faith and realizing I was ...

Dr. Joshua Sabari and Jackie Herigodt discuss the Imerman Angels organization and the importance of recognizing the person ...

Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses ...

For patients with metastatic HR+/HER2— breast cancer, there were various trials to have come out of ASCO 2025 that are worth keeping your eye on.

The bad news is you have ductal carcinoma in situ. The good news is that DCIS is the best type of breast cancer to get.

A study explores how prior authorization requirements; coverage stoppages and other red tape can generate barriers to life ...

I was diagnosed with follicular lymphoma in 2020, during COVID, which forced me to retire early and taught me I’m more than a ...

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

Breyanzi demonstrated a 95.5% response rate among patients with relapsed/refractory marginal zone lymphoma, as well as a ...

Both non-small lung cancer and small cell lung cancer is a disease that now has various therapeutic options available, ...

If there is ever an annual follow up CT scan that does not cause me significant anxiety, this year will be the one.